Pro-inflammatory innate-like T cells are expanded in the blood and inflamed intestine in Crohn's Disease

A complex and tissue-specific network of cells including T lymphocytes maintains intestinal homeostasis. To address disease and tissue-specific alterations, we performed a T cell-centric mass cytometry analysis of peripheral and intestinal lymphocytes from patients with Crohn's disease (CD) and healthy donor PBMCs. We compared inflamed and not inflamed tissue areas of bowel resections. Chronic inflammation enforced activation, exhaustion and terminal differentiation of CD4+ and CD8+ T cells and an enrichment of CD4+Foxp3+ cells (Tregs) in inflamed intestine. However, tissue-repairing Tregs decreased, while enigmatic rare Foxp3+ T-cell subsets appeared upon inflammation. In vitro assays revealed that those subsets, e.g. CD4+Foxp3+HLA-DR+TIGIT- and CD4+Foxp3+CD56+, express pro-inflammatory IFN-{gamma}. Some T-conventional (Tcon) cells tended towards innateness. In blood of CD patients, not well studied CD4+ and CD8+ subsets of CD16+CCR6+CD127+ T cells appeared anew, a phenotype reproducible by incubation of healthy blood T cells with patient blood plasma. Together, these findings suggest a bias towards innate-like pro-inflammatory Tregs and innate-like Tcon, which act with less specific cytotoxicity. Most likely, this is both cause and consequence of intestinal inflammation during CD.

[1]  Wei Li,et al.  Downregulation of TIGIT Expression in FOXP3+Regulatory T Cells in Acute Coronary Syndrome , 2022, Journal of inflammation research.

[2]  K. Dhama,et al.  Regulatory T cells (Tregs) and their therapeutic potential against autoimmune disorders – Advances and challenges , 2022, Human vaccines & immunotherapeutics.

[3]  J. Däbritz,et al.  New Insights on CD8+ T Cells in Inflammatory Bowel Disease and Therapeutic Approaches , 2021, Frontiers in Immunology.

[4]  Asha A. Nair,et al.  BMI1 maintains the Treg epigenomic landscape to prevent inflammatory bowel disease. , 2021, The Journal of clinical investigation.

[5]  P. Boor,et al.  Complement activation induces excessive T cell cytotoxicity in severe COVID-19 , 2021, Cell.

[6]  D. Farber Tissues, not blood, are where immune cells function , 2021, Nature.

[7]  R. Koup,et al.  Acquisition of optimal TFH cell function is defined by specific molecular, positional, and TCR dynamic signatures , 2021, Proceedings of the National Academy of Sciences.

[8]  Maxim N. Artyomov,et al.  Single-cell analyses of Crohn’s disease tissues reveal intestinal intraepithelial T cells heterogeneity and altered subset distributions , 2021, Nature Communications.

[9]  V. Niederlova,et al.  CD8+ Tregs revisited: A heterogeneous population with different phenotypes and properties , 2021, European journal of immunology.

[10]  J. Levitt,et al.  CD8+CD161+ T-Cells: Cytotoxic Memory Cells With High Therapeutic Potential , 2021, Frontiers in Immunology.

[11]  Hyun-Dong Chang,et al.  Deep phenotypical characterization of human CD3+CD56+ T cells by mass cytometry , 2020, European journal of immunology.

[12]  H. Ueno,et al.  Shared and distinct roles of T peripheral helper and T follicular helper cells in human diseases , 2020, Cellular & Molecular Immunology.

[13]  J. Waschke,et al.  Targeting desmosomal adhesion and signalling for intestinal barrier stabilization in inflammatory bowel diseases—Lessons from experimental models and patients , 2020, Acta physiologica.

[14]  G. Tseng,et al.  Single-Cell Analyses of Colon and Blood Reveal Distinct Immune Cell Signatures of Ulcerative Colitis and Crohn's Disease. , 2020, Gastroenterology.

[15]  D. Pellicci,et al.  Foxp3+ Tregs from Langerhans cell histiocytosis lesions co-express CD56 and have a definitively regulatory capacity. , 2020, Clinical immunology.

[16]  S. Brouard,et al.  Terminally Differentiated Effector Memory CD8+ T Cells Identify Kidney Transplant Recipients at High Risk of Graft Failure. , 2020, Journal of the American Society of Nephrology : JASN.

[17]  Brian D. Bennett,et al.  Single-Cell Analyses Identify Dysfunctional CD16+ CD8 T Cells in Smokers , 2020, Cell reports. Medicine.

[18]  M. Roncalli,et al.  NKp46-expressing human gut-resident intraepithelial Vδ1 T cell subpopulation exhibits high anti-tumor activity against colorectal cancer. , 2019, JCI insight.

[19]  Josef Spidlen,et al.  Automated optimized parameters for T-distributed stochastic neighbor embedding improve visualization and analysis of large datasets , 2019, Nature Communications.

[20]  L. Terracciano,et al.  Unique T-Cell Populations Define Immune-Inflamed Hepatocellular Carcinoma , 2019, Cellular and molecular gastroenterology and hepatology.

[21]  Andreas Grützkau,et al.  Stabilizing Antibody Cocktails for Mass Cytometry , 2019, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[22]  Samuel J. S. Rubin,et al.  Mass cytometry reveals systemic and local immune signatures that distinguish inflammatory bowel diseases , 2019, Nature Communications.

[23]  S. Baumgart,et al.  Osmium-Labeled Microspheres for Bead-Based Assays in Mass Cytometry , 2019, The Journal of Immunology.

[24]  R. Rad,et al.  Blimp1 Prevents Methylation of Foxp3 and Loss of Regulatory T Cell Identity at Sites of Inflammation , 2019, Cell reports.

[25]  H. Mei,et al.  Surface Barcoding of Live PBMC for Multiplexed Mass Cytometry. , 2019, Methods in molecular biology.

[26]  D. Merkler,et al.  Resident-Memory T Cells in Tissue-Restricted Immune Responses: For Better or Worse? , 2018, Front. Immunol..

[27]  M. Pirooznia,et al.  Human retinoic acid–regulated CD161+ regulatory T cells support wound repair in intestinal mucosa , 2018, Nature Immunology.

[28]  S. Kumari,et al.  Leishmania donovani mediated higher expression of CCL4 induces differential accumulation of CD4+CD56+NKT and CD8+CD56+NKT cells at infection site , 2018, Cytokine.

[29]  I. Noth,et al.  PD-1 up-regulation on CD4+ T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-β1 production , 2018, Science Translational Medicine.

[30]  M. Kaplan,et al.  Effector T Helper Cell Subsets in Inflammatory Bowel Diseases , 2018, Front. Immunol..

[31]  J. T. Kuenstner,et al.  Anti-microbial Antibodies, Host Immunity, and Autoimmune Disease , 2018, Front. Med..

[32]  Mark D. Robinson,et al.  Compensation of Signal Spillover in Suspension and Imaging Mass Cytometry , 2018, Cell systems.

[33]  P. Klenerman,et al.  Innate‐like CD8+ T‐cells and NK cells: converging functions and phenotypes , 2018, Immunology.

[34]  C. Sina,et al.  The intestinal complement system in inflammatory bowel disease: Shaping intestinal barrier function. , 2018, Seminars in immunology.

[35]  STAT3 regulates cytotoxicity of human CD57+ CD4+ T cells in blood and lymphoid follicles , 2018, Scientific Reports.

[36]  E. Smits,et al.  CD56 in the Immune System: More Than a Marker for Cytotoxicity? , 2017, Front. Immunol..

[37]  A. Pera,et al.  Adaptive Memory of Human NK-like CD8+ T-Cells to Aging, and Viral and Tumor Antigens , 2016, Front. Immunol..

[38]  Asha A. Nair,et al.  The Role of the Histone Methyltransferase Enhancer of Zeste Homolog 2 (EZH2) in the Pathobiological Mechanisms Underlying Inflammatory Bowel Disease (IBD)* , 2016, The Journal of Biological Chemistry.

[39]  A. Yoshimura,et al.  Induced Regulatory T Cells: Their Development, Stability, and Applications. , 2016, Trends in immunology.

[40]  A. Chauhan Human CD4+ T-Cells: A Role for Low-Affinity Fc Receptors , 2016, Front. Immunol..

[41]  H. Maecker,et al.  Platinum‐conjugated antibodies for application in mass cytometry , 2016, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[42]  D. Owczarek,et al.  Endothelial dysfunction in inflammatory bowel diseases: Pathogenesis, assessment and implications. , 2016, World journal of gastroenterology.

[43]  V. Kuchroo,et al.  TIGIT predominantly regulates the immune response via regulatory T cells , 2024, The Journal of clinical investigation.

[44]  Xin Yu,et al.  Identification of a FOXP3+CD3+CD56+ population with immunosuppressive function in cancer tissues of human hepatocellular carcinoma , 2015, Scientific Reports.

[45]  H. Maecker,et al.  Barcoding of Live Human Peripheral Blood Mononuclear Cells for Multiplexed Mass Cytometry , 2015, The Journal of Immunology.

[46]  H. Maecker,et al.  Multiparameter Phenotyping of Human PBMCs Using Mass Cytometry. , 2015, Methods in molecular biology.

[47]  Yufeng Shen,et al.  Spatial Map of Human T Cell Compartmentalization and Maintenance over Decades of Life , 2014, Cell.

[48]  A. Stadnyk,et al.  The Complement System in Inflammatory Bowel Disease , 2014, Inflammatory bowel diseases.

[49]  M. Huber,et al.  IRF4 at the crossroads of effector T‐cell fate decision , 2014, European journal of immunology.

[50]  P. Klenerman,et al.  CD161++CD8+ T cells, including the MAIT cell subset, are specifically activated by IL-12+IL-18 in a TCR-independent manner , 2013, European journal of immunology.

[51]  F. Sallusto,et al.  The who's who of T‐cell differentiation: Human memory T‐cell subsets , 2013, European journal of immunology.

[52]  G. Corazza,et al.  The role of interleukin 17 in Crohn’s disease-associated intestinal fibrosis , 2013, Fibrogenesis & tissue repair.

[53]  J. O’Shea,et al.  Mechanisms underlying helper T-cell plasticity: implications for immune-mediated disease. , 2013, The Journal of allergy and clinical immunology.

[54]  D. Bending,et al.  CD161 defines the subset of FoxP3+ T cells capable of producing proinflammatory cytokines. , 2013, Blood.

[55]  S. Nutt,et al.  Differentiation and function of Foxp3(+) effector regulatory T cells. , 2013, Trends in immunology.

[56]  P. Klenerman,et al.  CD161-Expressing Human T Cells , 2011, Front. Immun..

[57]  M. Vatn,et al.  Increase of regulatory T cells in ileal mucosa of untreated pediatric Crohn's disease patients , 2011, Scandinavian journal of gastroenterology.

[58]  F. Ghiringhelli,et al.  Human FOXP3 and cancer , 2010, Oncogene.

[59]  M. Neurath,et al.  Smad7 controls resistance of colitogenic T cells to regulatory T cell-mediated suppression. , 2009, Gastroenterology.

[60]  Erin E. Murphy,et al.  Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation , 2009, The Journal of experimental medicine.

[61]  Keiichiro Suzuki,et al.  Preferential Generation of Follicular B Helper T Cells from Foxp3+ T Cells in Gut Peyer's Patches , 2009, Science.

[62]  Z. Sun,et al.  The roles of CCR6 in migration of Th17 cells and regulation of effector T-cell balance in the gut , 2009, Mucosal Immunology.

[63]  H. Ljunggren,et al.  Elevated Numbers of FcγRIIIA+ (CD16+) Effector CD8 T Cells with NK Cell-Like Function in Chronic Hepatitis C Virus Infection1 , 2008, The Journal of Immunology.

[64]  H. Vié,et al.  Effector memory alphabeta T lymphocytes can express FcgammaRIIIa and mediate antibody-dependent cellular cytotoxicity. , 2008, Journal of immunology.

[65]  K. Papadakis,et al.  Characterization of FOXP3+CD4+ regulatory T cells in Crohn's disease. , 2007, Clinical immunology.

[66]  M. Neurath,et al.  Isolation and subsequent analysis of murine lamina propria mononuclear cells from colonic tissue , 2007, Nature Protocols.

[67]  T. Gingeras,et al.  CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells , 2006, The Journal of experimental medicine.

[68]  T. Giese,et al.  Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease. , 2005, Gastroenterology.

[69]  Li Li,et al.  Conversion of Peripheral CD4+CD25− Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-β Induction of Transcription Factor Foxp3 , 2003, The Journal of experimental medicine.

[70]  F. Ramsdell,et al.  An essential role for Scurfin in CD4+CD25+ T regulatory cells , 2003, Nature Immunology.

[71]  A. Rudensky,et al.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells , 2003, Nature Immunology.

[72]  T. Nomura,et al.  Control of Regulatory T Cell Development by the Transcription Factor Foxp3 , 2002 .

[73]  O. Mandelboim,et al.  Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[74]  T. Mak,et al.  The Transcription Factor Interferon Regulatory Factor 1 (IRF-1) Is Important during the Maturation of Natural Killer 1.1+ T Cell Receptor–α/β+ (NK1+ T) Cells, Natural Killer Cells, and Intestinal Intraepithelial T Cells , 1998, The Journal of experimental medicine.

[75]  I. Leodolter [Crohn's disease]. , 1967, Wiener Zeitschrift fur innere Medizin und ihre Grenzgebiete.